Non-inferiority trial versus PAXLOVID ® assessing safety and efficacy, including rates of disease rebound and incidence of Long COVID development, of ratutrelvir, a ritonavir-free anti-viral treatment ...
Traws Pharma reports interim Phase 2 data showing ratutrelvir performed comparably to Paxlovid in mild-to-moderate COVID-19 ...
39% (11 SAEs in 28 Patients) in Placebo Arm as Compared to Only 14% (8 SAEs in 56 Patients) in Leronlimab Arm Reported Serious Adverse Events (SAEs), Which Were Unrelated to Leronlimab. The Efficacy ...
TÜBINGEN, GERMAN and BOSTON, MA / ACCESSWIRE / November 1, 2023 / CureVac N.V. (NASDAQ:CVAC) ("CureVac"), a global biopharmaceutical company developing a new class of transformative medicines based on ...
Mobile Community Clinical Research Facility to be Deployed in California ATLANTA, GA, Feb. 15, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire – GeoVax Labs, Inc. (Nasdaq: GOVX), a biotechnology company ...
The Chosun Ilbo on MSNOpinion
mRNA vaccine phase 1 again, begging US pharma?
I was taken aback to hear the government had selected GC Biopharma as a company to support in phase 1 (first-stage clinical ...
to initiate Phase 2 study evaluating masitinib in combination with isoquercetin for the treatment of COVID-19 Company to host live webcast on Monday May 11, 2020, 5.30pm CET AB Science SA (NYSE ...
Phase 2 of Governor Roy Cooper's COVID-19 reopening plan was extended for another three weeks. This means gyms will have to remain closed until July 17 when officials access the number of COVID-19 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback